The composition of cell wall skeleton and outermost lipids of Mycobacterium vaccae is modified by ethambutol treatment

Polish Journal of Microbiology

Volumn 57, Issue 2, 2008, Pages 99-104

  Rumijowska Galewicz, Anna ^a   Korycka Machała, Małgorzata ^a   Lisowska, Katarzyna ^b   Dziadek, Jarosław ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

Ethambutol; Mycobacterial cell wall skeleton; Permeability

Indexed keywords

ARABINOSE; ETHAMBUTOL; GALACTOSE; MEMBRANE LIPID; MYCOLIC ACID; SITOSTEROL; ARABINOGALACTAN; BACTERIAL POLYSACCHARIDE; CELL WALL SKELETON; GALACTAN; GLYCOLIPID; PHOSPHOLIPID; SITOSTEROL DERIVATIVE; TUBERCULOSTATIC AGENT;

ARTICLE; BACTERIAL CELL WALL; BACTERIAL GROWTH; BIOTRANSFORMATION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DECOMPOSITION; DRUG EXPOSURE; DRUG SENSITIVITY; FATTY ACID ANALYSIS; GAS CHROMATOGRAPHY; LIPID COMPOSITION; MASS SPECTROMETRY; MYCOBACTERIUM VACCAE; NONHUMAN; DRUG ANTAGONISM; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; MASS FRAGMENTOGRAPHY; METABOLISM; MYCOBACTERIUM;

ARA; MYCOBACTERIUM VACCAE;

ANTITUBERCULAR AGENTS; ARABINOSE; CELL MEMBRANE PERMEABILITY; CELL WALL SKELETON; ETHAMBUTOL; GALACTANS; GALACTOSE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLYCOLIPIDS; MYCOBACTERIUM; MYCOLIC ACIDS; PHOSPHOLIPIDS; POLYSACCHARIDES, BACTERIAL; SITOSTEROLS;

EID: 48249118010     PISSN: 17331331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Azuma I., E.E. Ribi, T.J. Meyer and B. Zbar. 1974. Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P 3. J. Natl. Cancer Inst. 52: 95-101.
2. Belanger A.E., G.S. Besra, M.E. Ford, K. Mikusova, J.T. Belisle, P.J. Brennan and J.M. Inamine. 1996. The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. Proc. Natt. Acad. Sci. USA 93: 11919-11924.
3. Brennan P.J. and H. Nikaido. 1995. The envelope of mycobacteria. Annu. Rev. Biochem. 64: 29-63.
4. Connel N.D. and H. Nikaido. 1994. Membrane permeability and transport in Mycobacterium tuberculosis. pp 333-352. In: Bloom B.R. (ed). Tuberculosis Pathogenesis, Protection and Control, AFM Press, Washington, D C.
5. Crick D.C., S. Mahapatra and P.J. Brennan. 2001. Biosynthesis of arabinogalactan-peptidoglycan complex of Mycobacterium tuberculosis. Glycobiology 11: 107-118.
6. Daffe M. and P. Draper. 1998. The envelope layers of mycobacteria with reference to their pathogenicity. Adv. Microbiol. Physiol. 39: 131-203.
7. David H.L., N. Rastogi, S. Clavel-Seres and F. Clement. 1988. Alteration in the outer wall architecture caused by the inhibition of mycoside C biosynthesis in Mycobacterium avium. Curr. Microbiol. 17: 61-68.
8. Deng L., K. Mikusova, K.G. Robuck, M. Scherman, P.J. Brennan and M.R. McNeil. 1995. Recognition of multiple effects of ehtambutol on metabolism of mycobacterial cell envelope. Antimicrob. Agents Chemother. 39: 694-701.
9. Gamian A., H. Mordarska, I. Ekiel, J. Ulrich, B. Szponar and J. Defaye. 1996. Structural studies of the major glycolipid from Saccharopolyspora genus. Carbohyd. Res. 296: 55-67.
10. Garcia-Borcelo M., M. Luquin, F. Belda and V. Ausina. 1993. Gas chromatographic whole-cell fatty acid analysis as an aid for the identification of mixed mycobacterial cultures. J. Chrom. 617: 299-303.
11. Häusler H., R.P. Kawakami, E. Mlaker, W.B. Severn and A.E. Stütz. 2001. Ethambutol analogues as potential antimycobacterial agents. Bioorg. Med. Chem. Letters 11: 1679-1681.
12. Hunter S.W., M. McNeil, R.L. Modlin, V. Mehra, B.R. Bloom and P.J. Brennan. 1989. Isolation and characterisation of the highly immunogenic cell wall-associated protein of Mycobacterium leprae. J. Immun. 142: 2864-2872.
13. Jackson M., C. Raynaud, M.A. Laneelle, Ch. Guilhot, Ch. Laurent-Winter, D. Ensergueix, B. Gicquel and M. Daffe. 1999. Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope. Mol. Microbiol. 31: 1573-1587.
14. Jarlier V. and H. Nikaido. 1990. Permeability barrier to hydrofilic solutes in Mycobacterium chelonae. J. Bacteriol. 172: 1418-1423.
15. Korycka-Machała M., A. Ziółkowski, A. Rumijowska-Galewicz, K. Lisowska and L. Sedlaczek. 2001. Polycations increase the permeability of Mycobacterium vaccae cell envelopes to hydrophobic compounds. Microbiology 147: 2769-2781.
16. Korycka-Machała M., A. Rumijowska-Galewicz and J. Dziadek. 2005. The effect of ethambutol on the mycobacterial cell wall permeability to hydrophobic compounds. Pol. J. Microbiol. 54: 5-11.
17. Koul A. and R. Prasad. 1996. Extraction of membrane lipids. pp. 36-51. In Prasad R. (ed). Manual on Membrane Lipids. Springer - Verlag Berlin Heidelberg.
18. Lisowska K., M. Korycka, O. Hadław-Klimaszewska, A. Ziółkowski and L. Sedlaczek. 1996. Permeability of mycobacterial cell envelopes to sterols: peptidoglycan as the diffusion barrier. J. Basic Microbiol. 36: 407-419.
19. Liu J., C.E. Barry, G.S. Besra and H. Nikaido. 1996. Mycolic acid structure determines the fluidity of the mycobacterial cell wall. J. Biol. Chem. 271: 29545-29551.
20. Liu J., E.Y. Rosenberg and H. Nikaido. 1995. Fluidity of the lipid domain of cell wall from Mycobacterium chelonae. Proc. Natl. Acad. Sci. USA 92: 11254-11258.
21. McNeil M. 1999. Arabinogalactan in mycobacteria: structure, biosynthesis and genetics. pp 207-223. In: Goldberg J.B. (ed). Genetics of Bacterial Polysaccharides, CRC Press, Washington, DC.
22. Minnikin D.E., G. Hutchinson, A.B. Caldicott and M. Goodfellow. 1980. Thin-layer chromatography of methanolysates of mycolic acid-containing bacteria. J. Chrom. 188: 221-233.
23. Nikaido H. and V. Jarlier. 1991. Permeability of the mycobacterial cell wall. Res. Microbiol. 142: 437-443.
24. Nikaido H., S.H. Kim and E.Y. Rosenberg. 1993. Physical organization of lipids in the cell wall of Mycobacterium chelonae. Mol. Microbiol. 8: 1025-1030.
25. Pathak A.K., V. Pathak, J.M. Riordan, S.S. Gurcha, G.S. Besra and R.C. Reynolds. 2004. Synthesis of mannopyranose disaccharides as photoaffinity probes for mannosyltransferases in Mycobacterium tuberculosis. Carboh. Res. 339: 683-691.
26. Puech V., N. Bayan, K. Salim, G. Leblan and M. Daffe. 2000. Characterization of the in vivo acceptors of the mycoloyl residues transferred by the corynebacterial PSI and the related mycobacterial antigen 85. Mol. Microbiol. 35: 1026-1041.
27. Radmacher E., K.C. Stansen, G.S. Besra, L.J. Alderwick, W.N. Maughan, G. Hollweg, H. Sahm, V.F. Wendisch and L. Eggeling. 2005. Ethambutol, a cell wall inhibitor of Mycobacterium tuberculosis, elicits L-glutamate efflux of Corynebacterium glutamicum. Microbiology 151: 1359-68.
28. Ramalho T.C., E.F..F da Cunha and R.B. de Alencastro. 2004. A density functional study on the complexation of ethambutol with divalent cations. J. Mol. Struct. Theoehem. 676: 149-153.
29. Ramaswamy S. and J.M. Musser. 1998. Molecular genetic basic of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuberc. Lung Dis. 79: 3-9.
30. Rastogi N. 1991. Recent observations concerning structure and function relationships in the mycobacterial cell envelope: elaboration of a model in terms of mycobacterial pathogenicity, virulence and drug-resistance. Res. Microbiol. 142: 464-476.
31. Rumijowska A., K. Lisowska, A. Ziółkowski and L. Sedlaczek. 1997. Transformation of sterols by Mycobacterium vaccae: effect of lecithin on the permeability of cell envelopes to sterols. World J. Microbiol. Biotechnol. 13: 89-95.
32. Rumijowska-Galewicz A., A. Ziółkowski, M. Korycka-Machala and L. Sedlaczek. 2000. Alterations in lipid composition of Mycobacterium vaccae cell wall outer layer enhance β-sitosterol degradation. World J. Biol. Biotechnol. 16: 237-244.
33. Sedlaczek L., B.M. G)acormiński and K. Lisowska. 1994. Effect of inhibitors of cell envelope synthesis on β-sitosterol side chain degradation by Mycobacterium sp. NRRL 3683. J. Basic Microbiol. 34: 387-399.
34. Sedlaczek L., K. Lisowska, M. Korycka, A. Rumijowska, A. Ziółkowski and J. Długoński. 1999. The effect of cell wall components on glycine-enhanced sterol side chain degradation to androstene derivatives by mycobacteria. Appl. Microbiol. Biotechnol. 52: 563-571.
35. Sirgel F.A., P.R. Donald, J. Odhiambo, W. Githui, K.C. Umapathy, C.N. Paramasivan, C.M. Tam, K.M. Kam, C.W. Lam, K.M. Sole, D.A. Mitchison and others. 2000. A multicentre study of the early bactericidal activity of anti-tuberculosis drugs. J. Antimicrob. Chemother. 45: 859-870.
36. Szentirmai A. 1990. Microbial physiology of side chain degradation of sterols. J. Ind. Microbiol. 6: 101-115.
37. Takayama K. and J.O. Kilburn. 1989. Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 33: 1493-1499.
38. Valero-Guillen P.L. and F. Martin-Luengo. 1986. 1-Tetradecanol, a new alcohol found in the cell wall of some rapidly growing chromogenic mycobacteria. FEMS Microbiol. Letters 35: 59-63.
39. Xin Y., Y. Huang and M.R. McNeil. 1999. The presence of an endogenous endo-D-arabinase in Mycobacterium smegmatis and characterization of its oligoarabinoside product. Biochim. Biophys. Acta 1473: 267-271.